Source: Business Wire

Press Release: PSG : PSG Announces New Features Designed to Support Biosimilar Strategy

DALLAS & SAN FRANCISCO--(BUSINESS WIRE)-- #biosimilars--Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform, Artemetrx®, which will significantly enhance clients' ability to track and report on the adoption of biosimilar medications. Artemetrx is the leading integrated pharmacy and medical claims platform and is utilized by health plans, pharmacy benefit managers, and employers for drug cost management. While biosimilars have been available in th

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Dave Borden's photo - CEO of PSG

CEO

Dave Borden

CEO Approval Rating

90/100

Read more